The March edition of the 1Cell.Ai Newsletter takes a closer look at how AI is changing the future of cancer care in ways that are becoming more practical and meaningful for doctors and patients alike. From the growing discussion around AlphaGenome to real-world applications of AI in breast cancer care, this issue brings together some of the most important developments in precision oncology today.
One of the highlights is OncoPredikt BreastRS, an AI-powered solution that helps assess breast cancer recurrence risk using routine pathology slides making advanced insights more accessible and affordable for patients across India. The newsletter also shares a real patient case where AI-supported analysis helped avoid unnecessary chemotherapy and reduce treatment burden.
You’ll also find updates from the global oncology space, including new biomarker-driven therapies, advances in lung cancer treatment, and how AI is helping researchers discover better drug targets faster.
If you want to understand how technology is quietly reshaping cancer treatment and decision-making, this edition is a thoughtful and easy read worth downloading.